Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial

americanpharmaceuticalreviewApril 11, 2019

Tag: FDA , GT Biopharma , human , GTB-3550 , trial

PharmaSources Customer Service